SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '6c9d'

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)	View	Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1E7A_A_PFLA4001_1 (SERUM ALBUMIN)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	5 / 9	LEU A  76 LEU A 700 ARG A 698 GLY A 142 ALA A 139	None	1.24A	1e7aA-6c9dA: undetectable	1e7aA-6c9dA: 8.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FMO_E_ADNE351_1 (CAMP-DEPENDENT PROTEIN KINASE)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 12	GLY A  67 VAL A  74 ALA A  87 VAL A 120 ASN A 187 LEU A 189 ASP A 200	None	0.61A	1fmoE-6c9dA: 30.0	1fmoE-6c9dA: 12.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1IEP_A_STIA201_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 12	VAL A  74 ALA A  87 GLU A 107 MET A 111 GLY A 142 LEU A 189 ALA A 199	None	0.99A	1iepA-6c9dA: 21.0	1iepA-6c9dA: 14.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1IEP_B_STIB202_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	6 / 12	VAL A  74 ALA A  87 GLU A 107 MET A 111 GLY A 142 ALA A 199	None	0.91A	1iepB-6c9dA: 21.1	1iepB-6c9dA: 14.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MUO_A_ADNA1_1 (AURORA-RELATED KINASE 1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	6 / 9	GLY A  67 VAL A  74 ALA A  87 TYR A 138 ALA A 139 LEU A 189	None	0.66A	1muoA-6c9dA: 10.4	1muoA-6c9dA: 12.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1OPJ_B_STIB4_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 12	VAL A  74 ALA A  87 GLU A 107 MET A 111 VAL A 120 GLY A 142 ALA A 199	None	0.92A	1opjB-6c9dA: 21.1	1opjB-6c9dA: 14.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1TDN_A_LEUA487_0 (L-AMINO ACID OXIDASE)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	4 / 7	ASN A 187 HIS A 180 PHE A 201 ILE A 166	None	1.30A	1tdnA-6c9dA: undetectable	1tdnA-6c9dA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2BXM_A_IMNA2001_1 (SERUM ALBUMIN)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	4 / 8	SER A 776 ALA A 781 PHE A 782 ALA A 786	None	0.89A	2bxmA-6c9dA: undetectable	2bxmA-6c9dA: 8.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EUF_B_LQQB401_1 (CELL DIVISION PROTEIN KINASE 6)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	8 / 12	ILE A  66 VAL A  74 LYS A  89 VAL A 120 ASN A 187 LEU A 189 ALA A 199 ASP A 200	None	0.82A	2eufB-6c9dA: 27.5	2eufB-6c9dA: 12.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EVA_A_ADNA498_1 (TAK1 KINASE - TAB1 CHIMERA FUSION PROTEIN)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 11	GLY A  67 VAL A  74 ALA A  87 MET A 136 TYR A 138 ALA A 139 LEU A 189	None	0.66A	2evaA-6c9dA: 22.7	2evaA-6c9dA: 14.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_A_MIXA539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 12	GLY A  67 VAL A  74 ALA A  87 ASP A 182 LYS A 184 ASN A 187 ASP A 200	None	0.78A	2fumA-6c9dA: 27.0	2fumA-6c9dA: 15.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_B_MIXB1539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	8 / 12	GLY A  67 VAL A  74 ALA A  87 MET A 136 TYR A 138 LYS A 184 ASN A 187 ASP A 200	None	0.79A	2fumB-6c9dA: 27.0	2fumB-6c9dA: 15.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_C_MIXC2539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	6 / 12	GLY A  67 VAL A  74 ALA A  87 MET A 136 TYR A 138 ASN A 187	None	0.59A	2fumC-6c9dA: 25.2	2fumC-6c9dA: 15.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HYY_A_STIA600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 12	VAL A  74 ALA A  87 GLU A 107 MET A 111 GLY A 142 LEU A 189 ALA A 199	None	0.98A	2hyyA-6c9dA: 21.2	2hyyA-6c9dA: 16.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HYY_B_STIB600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 12	VAL A  74 ALA A  87 GLU A 107 MET A 111 GLY A 142 LEU A 189 ALA A 199	None	0.97A	2hyyB-6c9dA: 21.3	2hyyB-6c9dA: 16.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HYY_D_STID600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	6 / 12	VAL A  74 ALA A  87 GLU A 107 MET A 111 LEU A 189 ALA A 199	None	0.91A	2hyyD-6c9dA: 21.0	2hyyD-6c9dA: 16.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OIQ_A_STIA1001_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	8 / 12	VAL A  74 ALA A  87 LYS A  89 GLU A 107 MET A 111 TYR A 138 LEU A 189 ALA A 199	None	1.02A	2oiqA-6c9dA: 21.7	2oiqA-6c9dA: 14.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OIQ_A_STIA1001_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	8 / 12	VAL A  74 LYS A  89 GLU A 107 MET A 111 TYR A 138 GLY A 142 LEU A 189 ALA A 199	None	1.10A	2oiqA-6c9dA: 21.7	2oiqA-6c9dA: 14.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PL0_A_STIA200_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE LCK)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	8 / 12	ALA A  87 LYS A  89 GLU A 107 MET A 111 VAL A 120 TYR A 138 LEU A 189 ALA A 199	None	1.24A	2pl0A-6c9dA: 21.0	2pl0A-6c9dA: 12.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6O_A_1N1A1892_1 (EPHRIN TYPE-A RECEPTOR 4)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 12	LYS A  64 ILE A  66 ALA A  87 LYS A  89 GLU A 107 MET A 111 TYR A 138	None	0.68A	2y6oA-6c9dA: 22.1	2y6oA-6c9dA: 17.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6O_A_1N1A1892_1 (EPHRIN TYPE-A RECEPTOR 4)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 12	LYS A  64 ILE A  66 ALA A  87 LYS A  89 MET A 111 TYR A 138 LEU A 189	None	0.91A	2y6oA-6c9dA: 22.1	2y6oA-6c9dA: 17.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CS9_C_NILC600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	5 / 12	ALA A  87 GLU A 107 MET A 111 HIS A 180 ALA A 199	None	0.87A	3cs9C-6c9dA: 21.0	3cs9C-6c9dA: 16.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G5D_B_1N1B1_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	8 / 12	VAL A  74 ALA A  87 LYS A  89 MET A 111 VAL A 120 TYR A 138 LEU A 189 ALA A 199	None	0.75A	3g5dB-6c9dA: 23.0	3g5dB-6c9dA: 14.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GVU_A_STIA1001_1 (TYROSINE-PROTEIN KINASE ABL2)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 12	VAL A  74 ALA A  87 GLU A 107 MET A 111 VAL A 120 LEU A 189 ALA A 199	None	0.88A	3gvuA-6c9dA: 21.8	3gvuA-6c9dA: 15.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3K5V_A_STIA2_1 (TYROSINE-PROTEIN KINASE ABL1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 12	VAL A  74 ALA A  87 GLU A 107 MET A 111 GLY A 142 LEU A 189 ALA A 199	None	0.98A	3k5vA-6c9dA: 16.1	3k5vA-6c9dA: 14.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3K5V_B_STIB2_1 (TYROSINE-PROTEIN KINASE ABL1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 12	VAL A  74 ALA A  87 GLU A 107 MET A 111 GLY A 142 LEU A 189 ALA A 199	None	0.97A	3k5vB-6c9dA: 20.8	3k5vB-6c9dA: 14.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LXK_A_MI1A1125_1 (TYROSINE-PROTEIN KINASE JAK3)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	10 / 12	GLY A  67 VAL A  74 ALA A  87 LYS A  89 VAL A 120 MET A 136 TYR A 138 LEU A 189 ALA A 199 ASP A 200	None	1.04A	3lxkA-6c9dA: 24.5	3lxkA-6c9dA: 14.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MS9_A_STIA1_1 (TYROSINE-PROTEIN KINASE ABL1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	6 / 12	VAL A  74 ALA A  87 GLU A 107 MET A 111 LEU A 189 ALA A 199	None	0.94A	3ms9A-6c9dA: 20.8	3ms9A-6c9dA: 14.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MSS_A_STIA1_1 (TYROSINE-PROTEIN KINASE ABL1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	6 / 12	VAL A  74 ALA A  87 GLU A 107 MET A 111 LEU A 189 ALA A 199	None	0.95A	3mssA-6c9dA: 21.0	3mssA-6c9dA: 14.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MSS_C_STIC1_1 (TYROSINE-PROTEIN KINASE ABL1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	6 / 12	VAL A  74 ALA A  87 GLU A 107 MET A 111 LEU A 189 ALA A 199	None	0.93A	3mssC-6c9dA: 21.0	3mssC-6c9dA: 14.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MSS_D_STID1_1 (TYROSINE-PROTEIN KINASE ABL1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	6 / 12	ALA A  87 GLU A 107 MET A 111 GLY A 142 LEU A 189 ALA A 199	None	1.00A	3mssD-6c9dA: 21.0	3mssD-6c9dA: 14.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OEZ_B_STIB601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	8 / 12	VAL A  74 ALA A  87 LYS A  89 GLU A 107 MET A 111 TYR A 138 LEU A 189 ALA A 199	None	0.84A	3oezB-6c9dA: 22.0	3oezB-6c9dA: 13.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OXZ_A_0LIA1_1 (TYROSINE-PROTEIN KINASE ABL1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	6 / 12	ALA A  87 GLU A 107 MET A 111 VAL A 120 HIS A 180 ALA A 199	None	0.81A	3oxzA-6c9dA: 21.1	3oxzA-6c9dA: 14.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3PYY_B_STIB4_1 (V-ABL ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1 ISOFORM B VARIANT)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 12	VAL A  74 ALA A  87 GLU A 107 MET A 111 VAL A 120 LEU A 189 ALA A 199	None	0.85A	3pyyB-6c9dA: 16.3	3pyyB-6c9dA: 15.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RGF_A_BAXA465_1 (CYCLIN-DEPENDENT KINASE 8)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 12	VAL A  74 ALA A  87 GLU A 107 TYR A 138 ALA A 139 HIS A 180 ALA A 199	None	0.85A	3rgfA-6c9dA: 22.3	3rgfA-6c9dA: 11.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SG9_B_KANB305_1 (APH(2'')-ID)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	4 / 8	SER A 219 ASP A 258 GLU A 186 GLU A 143	None	0.96A	3sg9B-6c9dA: 8.1	3sg9B-6c9dA: 16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U40_B_ADNB251_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	5 / 10	ARG A 774 VAL A 144 GLU A 143 GLU A 186 HIS A 180	None	1.47A	3u40B-6c9dA: undetectable 3u40C-6c9dA: undetectable	3u40B-6c9dA: 15.19 3u40C-6c9dA: 15.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U40_C_ADNC251_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	5 / 12	HIS A 180 ARG A 774 VAL A 144 GLU A 143 GLU A 186	None	1.46A	3u40B-6c9dA: undetectable 3u40C-6c9dA: undetectable	3u40B-6c9dA: 15.19 3u40C-6c9dA: 15.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U40_D_ADND251_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	5 / 11	ARG A 774 VAL A 144 GLU A 143 GLU A 186 HIS A 180	None	1.50A	3u40D-6c9dA: undetectable 3u40E-6c9dA: undetectable	3u40D-6c9dA: 15.19 3u40E-6c9dA: 15.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U40_F_ADNF251_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	5 / 10	HIS A 180 ARG A 774 VAL A 144 GLU A 143 GLU A 186	None	1.46A	3u40A-6c9dA: undetectable 3u40F-6c9dA: undetectable	3u40A-6c9dA: 15.19 3u40F-6c9dA: 15.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9F_B_CLMB221_0 (CHLORAMPHENICOL ACETYLTRANSFERASE)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	5 / 12	THR A 778 SER A 779 PHE A 145 LEU A 265 VAL A 269	None	1.23A	3u9fB-6c9dA: undetectable 3u9fC-6c9dA: undetectable	3u9fB-6c9dA: undetectable 3u9fC-6c9dA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9F_H_CLMH221_0 (CHLORAMPHENICOL ACETYLTRANSFERASE)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	5 / 12	THR A 778 SER A 779 PHE A 145 LEU A 265 VAL A 269	None	1.28A	3u9fH-6c9dA: undetectable 3u9fI-6c9dA: undetectable	3u9fH-6c9dA: undetectable 3u9fI-6c9dA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9F_L_CLML221_0 (CHLORAMPHENICOL ACETYLTRANSFERASE)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	5 / 12	THR A 778 SER A 779 PHE A 145 LEU A 265 VAL A 269	None	1.19A	3u9fJ-6c9dA: undetectable 3u9fL-6c9dA: undetectable	3u9fJ-6c9dA: undetectable 3u9fL-6c9dA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V4T_H_ACTH503_0 (UDP-N-ACETYLGLUCOSAM INE 1-CARBOXYVINYLTRANSF ERASE)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	4 / 7	ALA A 781 ILE A 785 HIS A 744 GLY A 745	None	0.94A	3v4tH-6c9dA: undetectable	3v4tH-6c9dA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	4 / 5	ILE A 110 VAL A 120 LEU A 189 ASP A 200	None	1.22A	3wzdA-6c9dA: 21.0	3wzdA-6c9dA: 11.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	4 / 5	LYS A  89 ILE A 110 VAL A 120 LEU A 189	None	1.00A	3wzdA-6c9dA: 21.0	3wzdA-6c9dA: 11.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ZOS_A_0LIA1000_2 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	5 / 9	ILE A 110 LEU A 114 ILE A 119 TYR A 138 ILE A 198	None	0.79A	3zosA-6c9dA: 21.2	3zosA-6c9dA: 11.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ZOS_A_0LIA1000_2 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	5 / 9	ILE A 110 MET A 111 ILE A 119 TYR A 138 ILE A 198	None	0.97A	3zosA-6c9dA: 21.2	3zosA-6c9dA: 11.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ZOS_B_0LIB1000_2 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	5 / 9	ILE A 110 LEU A 114 ILE A 119 TYR A 138 ILE A 198	None	0.80A	3zosB-6c9dA: 21.2	3zosB-6c9dA: 11.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ZOS_B_0LIB1000_2 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	5 / 9	ILE A 110 MET A 111 ILE A 119 TYR A 138 ILE A 198	None	0.98A	3zosB-6c9dA: 21.2	3zosB-6c9dA: 11.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BKJ_A_STIA1000_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	8 / 12	VAL A  74 ALA A  87 GLU A 107 ILE A 110 MET A 111 TYR A 138 LEU A 189 ALA A 199	None	1.36A	4bkjA-6c9dA: 21.0	4bkjA-6c9dA: 11.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BKJ_B_STIB1000_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 12	VAL A  74 ALA A  87 GLU A 107 ILE A 110 MET A 111 LEU A 189 ALA A 199	None	1.14A	4bkjB-6c9dA: 21.1	4bkjB-6c9dA: 11.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BKJ_B_STIB1000_2 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	4 / 5	LYS A  89 LEU A 114 TYR A 138 ARG A 181	None	1.14A	4bkjB-6c9dA: 21.1	4bkjB-6c9dA: 11.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_A_0LIA1000_2 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	4 / 5	VAL A  74 ILE A 119 TYR A 138 ILE A 198	None	0.49A	4c8bA-6c9dA: 22.1	4c8bA-6c9dA: 11.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_B_0LIB1000_1 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 12	ALA A  87 LYS A  89 GLU A 107 ILE A 119 HIS A 180 LEU A 189 ALA A 199	None	0.73A	4c8bB-6c9dA: 22.2	4c8bB-6c9dA: 11.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CKJ_A_ADNA2014_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 10	GLY A  67 GLY A  69 VAL A  74 ALA A  87 TYR A 138 ALA A 139 LEU A 189	None	0.73A	4ckjA-6c9dA: 26.1	4ckjA-6c9dA: 14.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CSV_A_STIA1265_1 (SRC-ABL TYROSINE KINASE ANCESTOR)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	9 / 12	VAL A  74 ALA A  87 GLU A 107 ILE A 110 MET A 111 VAL A 120 TYR A 138 LEU A 189 ALA A 199	None	1.04A	4csvA-6c9dA: 22.4	4csvA-6c9dA: 13.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IAA_A_RTZA401_1 (SERINE/THREONINE-PRO TEIN KINASE PIM-1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	6 / 11	VAL A  74 ALA A  87 LYS A  89 GLU A 186 LEU A 189 ASP A 200	None	1.01A	4iaaA-6c9dA: 28.2	4iaaA-6c9dA: 12.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KMM_B_CHDB503_0 (FERROCHELATASE, MITOCHONDRIAL)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	4 / 5	MET A 712 LEU A 795 ARG A 722 PRO A 697	None	1.46A	4kmmB-6c9dA: undetectable	4kmmB-6c9dA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OGR_A_ADNA401_1 (CYCLIN-DEPENDENT KINASE 9)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	6 / 8	ILE A  66 VAL A  74 ALA A  87 ASN A 187 LEU A 189 ASP A 200	None	0.86A	4ogrA-6c9dA: 27.2	4ogrA-6c9dA: 12.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OGR_I_ADNI401_1 (CYCLIN-DEPENDENT KINASE 9)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	6 / 9	ILE A  66 VAL A  74 ALA A  87 ASN A 187 LEU A 189 ASP A 200	None	0.89A	4ogrI-6c9dA: 27.0	4ogrI-6c9dA: 12.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OTI_A_MI1A1001_1 (SERINE/THREONINE-PRO TEIN KINASE N1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 12	GLY A  67 VAL A  74 ALA A  87 LYS A  89 VAL A 120 LEU A 189 ALA A 199	None	0.53A	4otiA-6c9dA: 23.5	4otiA-6c9dA: 14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OTW_A_DB8A1101_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 12	VAL A  74 LYS A  89 VAL A 120 TYR A 138 LEU A 189 ALA A 199 ASP A 200	None	1.04A	4otwA-6c9dA: 21.1	4otwA-6c9dA: 13.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OTW_A_DB8A1101_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 12	VAL A  74 VAL A 120 TYR A 138 GLY A 142 LEU A 189 ALA A 199 ASP A 200	None	0.88A	4otwA-6c9dA: 21.1	4otwA-6c9dA: 13.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QMN_A_DB8A401_1 (SERINE/THREONINE-PRO TEIN KINASE 24)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	6 / 12	ALA A  87 GLU A 107 TYR A 138 LEU A 189 ALA A 199 ASP A 200	None	0.54A	4qmnA-6c9dA: 29.3	4qmnA-6c9dA: 13.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QMS_A_1N1A401_1 (SERINE/THREONINE-PRO TEIN KINASE 24)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	6 / 11	ALA A  87 LYS A  89 GLU A 107 TYR A 138 LEU A 189 ASP A 200	None	0.79A	4qmsA-6c9dA: 21.7	4qmsA-6c9dA: 13.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QMZ_A_B49A401_1 (SERINE/THREONINE-PRO TEIN KINASE 24)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	6 / 12	ILE A  66 GLY A  67 VAL A  74 ALA A  87 TYR A 138 LEU A 189	None	0.79A	4qmzA-6c9dA: 21.6	4qmzA-6c9dA: 13.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QRC_A_0LIA802_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	5 / 12	ALA A  87 GLU A 107 MET A 111 ARG A 181 ALA A 199	None	0.75A	4qrcA-6c9dA: 22.4	4qrcA-6c9dA: 14.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R7I_A_STIA1001_1 (MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	6 / 12	VAL A  74 ALA A  87 LYS A  89 GLU A 107 MET A 111 LEU A 189	None	0.65A	4r7iA-6c9dA: 21.2	4r7iA-6c9dA: 15.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4TYJ_A_0LIA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 12	ALA A  87 GLU A 107 MET A 111 ALA A 139 HIS A 180 LEU A 189 ALA A 199	None	0.86A	4tyjA-6c9dA: 21.9	4tyjA-6c9dA: 12.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4TYJ_A_0LIA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 12	ALA A  87 GLU A 107 MET A 111 CYH A 173 HIS A 180 LEU A 189 ALA A 199	None	1.40A	4tyjA-6c9dA: 21.9	4tyjA-6c9dA: 12.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4U0I_A_0LIA1001_1 (MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT,MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 10	VAL A  74 GLU A 107 LEU A 114 ILE A 119 VAL A 120 TYR A 138 ILE A 198	None	0.83A	4u0iA-6c9dA: 21.3	4u0iA-6c9dA: 12.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4U0I_A_0LIA1001_1 (MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT,MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 10	VAL A  74 LEU A 114 ILE A 119 VAL A 120 TYR A 138 ARG A 181 ILE A 198	None	0.82A	4u0iA-6c9dA: 21.3	4u0iA-6c9dA: 12.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4UXQ_A_0LIA1752_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	4 / 7	VAL A  74 LYS A  89 MET A 111 ALA A 139	None	0.78A	4uxqA-6c9dA: 21.6	4uxqA-6c9dA: 14.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4UXQ_A_0LIA1752_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	5 / 7	VAL A  74 MET A 111 ALA A 139 ARG A 181 ILE A 198	None	0.92A	4uxqA-6c9dA: 21.6	4uxqA-6c9dA: 14.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V01_A_0LIA1776_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	6 / 12	ALA A  87 GLU A 107 MET A 111 ALA A 139 HIS A 180 ALA A 199	None	0.77A	4v01A-6c9dA: 21.2	4v01A-6c9dA: 12.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V01_A_0LIA1776_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	6 / 9	VAL A  74 LYS A  89 TYR A 138 ARG A 181 LEU A 189 ILE A 198	None	0.88A	4v01A-6c9dA: 21.2	4v01A-6c9dA: 12.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V01_B_0LIB1770_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	6 / 12	ALA A  87 GLU A 107 MET A 111 ALA A 139 HIS A 180 ALA A 199	None	0.76A	4v01B-6c9dA: 21.6	4v01B-6c9dA: 12.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V04_A_0LIA1772_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 12	VAL A  74 ALA A  87 GLU A 107 ALA A 139 HIS A 180 ALA A 199 GLY A 202	None	1.33A	4v04A-6c9dA: 21.2	4v04A-6c9dA: 12.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V04_A_0LIA1772_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	4 / 8	LYS A  89 TYR A 138 LEU A 189 ILE A 198	None	0.76A	4v04A-6c9dA: 21.2	4v04A-6c9dA: 12.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V04_A_0LIA1772_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	5 / 8	MET A 111 TYR A 138 ARG A 181 LEU A 189 ILE A 198	None	1.02A	4v04A-6c9dA: 21.2	4v04A-6c9dA: 12.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V04_B_0LIB1771_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 10	VAL A  74 LYS A  89 MET A 111 TYR A 138 ARG A 181 LEU A 189 ILE A 198	None	0.97A	4v04B-6c9dA: 21.9	4v04B-6c9dA: 12.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V04_B_0LIB1771_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	6 / 12	ALA A  87 GLU A 107 ALA A 139 HIS A 180 ALA A 199 GLY A 202	None	1.39A	4v04B-6c9dA: 21.9	4v04B-6c9dA: 12.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XLI_B_1N1B600_1 (NON-SPECIFIC PROTEIN-TYROSINE KINASE)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	8 / 12	ALA A  87 LYS A  89 MET A 111 VAL A 120 TYR A 138 GLY A 142 LEU A 189 ALA A 199	None	0.94A	4xliB-6c9dA: 24.7	4xliB-6c9dA: 15.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BVW_A_1N1A1009_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	8 / 12	VAL A  74 ALA A  87 LYS A  89 GLU A 107 MET A 111 TYR A 138 LEU A 189 ALA A 199	None	0.94A	5bvwA-6c9dA: 20.9	5bvwA-6c9dA: 11.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BVW_A_1N1A1009_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	8 / 12	VAL A  74 ALA A  87 LYS A  89 MET A 111 TYR A 138 GLY A 142 LEU A 189 ALA A 199	None	1.03A	5bvwA-6c9dA: 20.9	5bvwA-6c9dA: 11.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	5 / 7	GLY A  67 GLY A  69 PHE A  71 VAL A  74 LYS A  89	None	0.71A	5izjA-6c9dA: 29.1	5izjA-6c9dA: 13.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	5 / 7	GLY A  67 GLY A  69 PHE A  71 VAL A  74 LYS A  89	None	0.69A	5j5xA-6c9dA: 30.1	5j5xA-6c9dA: 13.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	5 / 7	GLY A  67 GLY A  69 VAL A  74 LYS A  89 ASP A 200	None	0.51A	5j5xA-6c9dA: 30.1	5j5xA-6c9dA: 13.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L2I_A_LQQA900_1 (CYCLIN-DEPENDENT KINASE 6)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 12	ILE A  66 GLY A  67 VAL A  74 ALA A  87 VAL A 120 LEU A 189 ALA A 199	None	0.91A	5l2iA-6c9dA: 7.8	5l2iA-6c9dA: 12.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LVN_A_ADNA402_1 (3-PHOSPHOINOSITIDE-D EPENDENT PROTEIN KINASE 1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 11	GLY A  67 VAL A  74 ALA A  87 VAL A 120 TYR A 138 ALA A 139 LEU A 189	None	0.40A	5lvnA-6c9dA: 26.4	5lvnA-6c9dA: 13.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LW1_B_ADNB401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	5 / 9	ILE A  66 GLY A  67 VAL A  74 ALA A  87 MET A 136	None	0.38A	5lw1B-6c9dA: 24.1	5lw1B-6c9dA: 28.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5N3H_A_NCAA401_0 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	6 / 10	VAL A  74 ALA A  87 VAL A 120 MET A 136 TYR A 138 LEU A 189	None	0.81A	5n3hA-6c9dA: 30.4	5n3hA-6c9dA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OWR_A_1N1A401_1 (SERINE/THREONINE-PRO TEIN KINASE 10)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	4 / 8	ALA A  87 GLU A 107 LEU A 189 ASP A 200	None	0.52A	5owrA-6c9dA: 21.8	5owrA-6c9dA: 14.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TE0_A_XINA401_1 (AP2-ASSOCIATED PROTEIN KINASE 1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 12	LEU A  76 ALA A  87 GLU A 107 MET A 111 VAL A 120 GLY A 142 LEU A 189	None	0.65A	5te0A-6c9dA: 28.1	5te0A-6c9dA: 14.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZNI_A_YMZA302_0 (PURINE NUCLEOSIDE PHOSPHORYLASE)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	5 / 9	GLY A 141 TYR A 147 GLU A 143 ASP A 191 GLY A 192	None	1.19A	5zniA-6c9dA: 2.0	5zniA-6c9dA: 22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HD4_A_STIA604_0 (TYROSINE-PROTEIN KINASE ABL1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	8 / 12	VAL A  74 ALA A  87 LYS A  89 GLU A 107 MET A 111 VAL A 120 LEU A 189 ALA A 199	None	0.99A	6hd4A-6c9dA: 21.0	6hd4A-6c9dA: 24.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HD4_B_STIB602_0 (TYROSINE-PROTEIN KINASE ABL1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 12	VAL A  74 ALA A  87 GLU A 107 MET A 111 VAL A 120 LEU A 189 ALA A 199	None	0.94A	6hd4B-6c9dA: 20.7	6hd4B-6c9dA: 24.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HD4_B_STIB602_0 (TYROSINE-PROTEIN KINASE ABL1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 12	VAL A  74 ALA A  87 LYS A  89 GLU A 107 MET A 111 VAL A 120 LEU A 189	None	0.95A	6hd4B-6c9dA: 20.7	6hd4B-6c9dA: 24.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HD6_A_STIA603_0 (TYROSINE-PROTEIN KINASE ABL1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	8 / 12	VAL A  74 ALA A  87 LYS A  89 GLU A 107 MET A 111 VAL A 120 LEU A 189 ALA A 199	None	1.00A	6hd6A-6c9dA: 16.1	6hd6A-6c9dA: 24.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HD6_B_STIB601_0 (TYROSINE-PROTEIN KINASE ABL1)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	7 / 12	VAL A  74 ALA A  87 LYS A  89 GLU A 107 MET A 111 VAL A 120 LEU A 189	None	1.00A	6hd6B-6c9dA: 20.8	6hd6B-6c9dA: 24.18